In many instances therapy can be switched from IV to oral once the patient has started to improve. Switching to an effective oral therapy reduces the incidence of hospital-acquired bacteraemias, allows earlier discharge, improves patient comfort and mobility and potentially significantly reduces the cost of treatment.
Patients may be considered for oral therapy if:
There is sufficient microbiological information about the pathogen and its sensitivities
Patients are:
Haemodynamically stable with no
signs of fever
Clinically improving
Able to take oral
medications, have a functional GI tract with no malabsorption and
there is no interactions with other medications
Not suffering from certain high-risk infections (see below)
Patients on intravenous antibiotics should usually be switched to oral therapy after 24-48 hours of IV therapy unless the following contra-indications apply:
Sepsis
Immunosuppression
Specific
instructions to continue from consultant / microbiologist
Nil by mouth /
vomiting / unable to swallow
Unconscious
Malabsorption
More than 1 of the following:
Temperature >38 C or <36 C
Tachycardia >90/min
Tachypnoea >20 breaths/min
WCC>12 or <4
Specific high-risk infections. These include:
Infective endocarditis
Prosthesis/implant/graft
infections
Liver abscesses
Adequately
drained abscesses and empyemas
Osteomyelitis
Septic arthritis
Severe cellulitis
Bronchiectasis
This is not an exhaustive list.
NOTE Penicillin V is usually not suitable for patients switching from IV therapy since its absorption is erratic.